Page last updated: 2024-11-08

biguanides and Carcinoid Tumor

biguanides has been researched along with Carcinoid Tumor in 1 studies

Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.

Carcinoid Tumor: A usually small, slow-growing neoplasm composed of islands of rounded, oxyphilic, or spindle-shaped cells of medium size, with moderately small vesicular nuclei, and covered by intact mucosa with a yellow cut surface. The tumor can occur anywhere in the gastrointestinal tract (and in the lungs and other sites); approximately 90% arise in the appendix. It is now established that these tumors are of neuroendocrine origin and derive from a primitive stem cell. (From Stedman, 25th ed & Holland et al., Cancer Medicine, 3d ed, p1182)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Herrera-Martínez, AD1
Pedraza-Arevalo, S1
L-López, F1
Gahete, MD1
Gálvez-Moreno, MA1
Castaño, JP1
Luque, RM1

Other Studies

1 other study available for biguanides and Carcinoid Tumor

ArticleYear
Type 2 Diabetes in Neuroendocrine Tumors: Are Biguanides and Statins Part of the Solution?
    The Journal of clinical endocrinology and metabolism, 2019, 01-01, Volume: 104, Issue:1

    Topics: Adult; Aged; Apoptosis; Biguanides; Carcinoid Tumor; Cell Line, Tumor; Cell Movement; Cell Prolifera

2019